Kira Pharmaceuticals
Latest round
- Series B
Last raised
- Jan 2021
Total raised
- $100M
Investors
- 9
About Kira Pharmaceuticals
Kira Pharmaceuticals Ltd., headquartered in Cambridge, US, focuses on creating therapies that modulate immune responses in various diseases. The company was co-founded by Gonghua Pan and Wenru Song.Kira Pharmaceuticals develops innovative therapies specifically targeting the complement system, crucial for various autoimmune and inflammatory diseases. Their primary offerings include investigational agents for conditions like IgA nephropathy, complement 3 glomerulopathy, and paroxysmal nocturnal hemoglobinuria.Kira Pharmaceuticals operates on a model emphasizing partnerships and collaborations with research institutions and healthcare organizations. Revenue is anticipated from successful clinical trials leading to the commercialization of their investigational products, particularly their lead asset, KP104.5 mn to advance their drug discovery platform and further develop complement therapies. The company is strategically targeting global markets for expansion, focusing on regions like the United States, China, and Australia.
Who invested in Kira Pharmaceuticals
9 investors across 4 rounds
See all investors in Kira Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kira Pharmaceuticals
Who invested in Kira Pharmaceuticals?
Kira Pharmaceuticals has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kira Pharmaceuticals raised?
Kira Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Kira Pharmaceuticals last raise money?
Kira Pharmaceuticals's most recent round on record is a Series B, in Jan 2021.
What does Kira Pharmaceuticals do?
Kira Pharmaceuticals is a biotechnology company.
Where is Kira Pharmaceuticals headquartered?
Kira Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Kira Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kira Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Kira Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.